ATE497171T1 - Von willebrand-faktor-aktivitätsnachweis - Google Patents

Von willebrand-faktor-aktivitätsnachweis

Info

Publication number
ATE497171T1
ATE497171T1 AT00947934T AT00947934T ATE497171T1 AT E497171 T1 ATE497171 T1 AT E497171T1 AT 00947934 T AT00947934 T AT 00947934T AT 00947934 T AT00947934 T AT 00947934T AT E497171 T1 ATE497171 T1 AT E497171T1
Authority
AT
Austria
Prior art keywords
vwf
gpib
willebrand factor
sample
von willebrand
Prior art date
Application number
AT00947934T
Other languages
English (en)
Inventor
Nancy Cauwenberghs
Karen Vanhoorelbeke
Hans Deckmyn
Original Assignee
Leuven K U Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8238516&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE497171(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leuven K U Res & Dev filed Critical Leuven K U Res & Dev
Application granted granted Critical
Publication of ATE497171T1 publication Critical patent/ATE497171T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/819—Multifunctional antigen or antibody

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT00947934T 1999-07-05 2000-07-05 Von willebrand-faktor-aktivitätsnachweis ATE497171T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99112967 1999-07-05
PCT/EP2000/006345 WO2001002853A2 (en) 1999-07-05 2000-07-05 DETECTION OF VON-WILLEBRANDFACTOR (vWF) ACTIVITY

Publications (1)

Publication Number Publication Date
ATE497171T1 true ATE497171T1 (de) 2011-02-15

Family

ID=8238516

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00947934T ATE497171T1 (de) 1999-07-05 2000-07-05 Von willebrand-faktor-aktivitätsnachweis

Country Status (6)

Country Link
US (2) US7622259B1 (de)
EP (2) EP1190260B1 (de)
AT (1) ATE497171T1 (de)
DE (1) DE60045577D1 (de)
ES (1) ES2358576T3 (de)
WO (1) WO2001002853A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE497171T1 (de) * 1999-07-05 2011-02-15 Leuven K U Res & Dev Von willebrand-faktor-aktivitätsnachweis
AU2003251238A1 (en) 2002-08-07 2004-02-25 Umc Utrecht Holding B.V. Modulation of platelet adhesion based on the surface exposed beta-switch loop of platelet glycoprotein ib-alpha
GB0229747D0 (en) * 2002-12-20 2003-01-29 Axis Shield Asa Assay
JP2006517789A (ja) 2003-01-10 2006-08-03 アブリンクス エン．ヴェー． 治療用ポリペプチド、その相同物、その断片、および血小板媒介凝集の調節での使用
WO2006074947A2 (en) * 2005-01-14 2006-07-20 Ablynx N.V. METHODS AND ASSAYS FOR DISTINGUISHING BETWEEN DIFFERENT FORMS OF DISEASES AND DISORDERS CHARACTERIZED BY THROMBOCYTOPENIA AND/OR BY SPONTANEOUS INTERACTION BETWEEN VON WILLEBRAND FACTOR (vWF) AND PLATELETS
CA2603732A1 (en) * 2005-04-22 2006-11-02 Wyeth Method for determination of glycoprotein ibalpha (gpibalpha) protein
ES2694247T3 (es) 2005-05-20 2018-12-19 Ablynx N.V. NanobodiesTM mejorados para el tratamiento de trastornos mediados por agregación
DE102006045550A1 (de) 2006-09-25 2008-04-03 Dade Behring Marburg Gmbh Verfahren zur Herstellung von agglutionationsfähigen Thrombozytenfragmenten und deren Verwendung
DE102007031708A1 (de) 2007-07-06 2009-01-08 Dade Behring Marburg Gmbh Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin
EP2193373A4 (de) * 2007-08-23 2010-07-28 Bloodct Of Wisconsin Inc Verfahren und kits zur messung des von-willebrand-faktors
US11644471B2 (en) 2010-09-30 2023-05-09 Ablynx N.V. Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
EP2671176B1 (de) 2011-01-31 2019-01-09 Fresenius Medical Care Holdings, Inc. Verhinderung von übermässiger freisetzung eines arzneistoffs
SG10201805064SA (en) 2011-06-23 2018-07-30 Ablynx Nv Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
EP2637024A1 (de) 2012-03-05 2013-09-11 Siemens Healthcare Diagnostics Products GmbH Screeningverfahren zum Auffinden von Proben mit einer Störung der Funktionalität der GPIb-Von Willebrand Faktor-Interaktion
EP2708892B1 (de) 2012-09-18 2015-04-15 Siemens Healthcare Diagnostics Products GmbH Verfahren zur Bestimmung Plättchen-assoziierter Analyten
WO2018053108A1 (en) * 2016-09-16 2018-03-22 Uenal Baris Microplates and open-channel microfluidics devices including coated and uncoated cellophane
CN111239120A (zh) * 2020-02-26 2020-06-05 绍兴市人民医院 一种血液钙离子检测试纸
JP7832621B2 (ja) * 2022-05-13 2026-03-18 国立大学法人北海道大学 フォン・ヴィレブランド因子の情報を取得する方法、測定試料の調製方法及び試薬キット

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
DE3174918D1 (en) * 1980-12-23 1986-08-14 Boehringer Mannheim Gmbh Hydrophilic latex particles, process for their preparation and their use
US4537861A (en) * 1983-02-03 1985-08-27 Elings Virgil B Apparatus and method for homogeneous immunoassay
US4789640A (en) * 1986-01-06 1988-12-06 The Salk Institute For Biological Studies Assays for myasthenia gravis
WO1989009622A1 (en) 1988-04-15 1989-10-19 Protein Design Labs, Inc. Il-2 receptor-specific chimeric antibodies
US5849536A (en) * 1990-03-02 1998-12-15 Bio-Technology General Corp. Cloning and production of human von willebrand factor GPIb binding domain polypeptides and methods of using same
DE4016885A1 (de) * 1990-05-25 1991-11-28 Behringwerke Ag Methode zur bestimmung des von-willebrand-faktors
US5321127A (en) * 1991-03-18 1994-06-14 Brigham And Women's Hospital Antiplatelet and antithrombotic activity of platelet glycoprotein Ib receptor fragments
US5317097A (en) * 1991-10-07 1994-05-31 The Research Foundation Of State University Of New York Mutations in the gene encoding the α chain on platelet glycoprotein IB
AT403764B (de) * 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
US5789261A (en) * 1996-10-30 1998-08-04 Temple University Of The Commonwealth System Of Higher Education Solid phase immunoassay
US6043871A (en) * 1997-03-03 2000-03-28 Brigham Young University System and method for measuring blood platelet function
ATE497171T1 (de) 1999-07-05 2011-02-15 Leuven K U Res & Dev Von willebrand-faktor-aktivitätsnachweis

Also Published As

Publication number Publication date
WO2001002853A3 (en) 2001-07-12
EP1190260B1 (de) 2011-01-26
DE60045577D1 (de) 2011-03-10
WO2001002853A2 (en) 2001-01-11
EP1190260A2 (de) 2002-03-27
EP2309275A1 (de) 2011-04-13
ES2358576T3 (es) 2011-05-11
US7622259B1 (en) 2009-11-24
US20100099202A1 (en) 2010-04-22

Similar Documents

Publication Publication Date Title
ATE497171T1 (de) Von willebrand-faktor-aktivitätsnachweis
DE69841085D1 (de) Gerät zur Bestimmung der Stickoxidkonzentration
DE60014348T8 (de) Messung und verwendung von molekularen wechselwirkungen
FI962448A7 (fi) Menetelmä, laite ja anturi fraktionaalisen happikyllästyksen määrittämistä varten
DE69836493D1 (de) Vorrichtung zur bestimmung von mehreren analyten
EP0957929A4 (de) Gefaesszellen wachstumsfaktor (vegf) nukleinsaureligand-komplexe
DE69723345D1 (de) Automatische Probenanalysevorrichtung
NO984355D0 (no) FremgangsmÕte for mÕling av en analytts konsentrasjon
DE69802295D1 (de) Seitenidentifizierung durch bestimmung von optischen eigenschaften
DE69130000D1 (de) Verfahren zur Messung, Analyse und Bestimmung der Bodenstruktur
ATE148923T1 (de) Funktioneller test und reagenz zur bestimmung von fibrinogen
DE69837015D1 (de) Verfahren zur Stabilisierung und Messung von Troponinkomplexen
DE69010143D1 (de) Testeinrichtung und Verfahren zur Bestimmung von Fructoasminen.
DK0946873T3 (da) Fremgangsmåde til diagnose af allergisk bronkopulmonal aspergillose
FI881704A7 (fi) Menetelmä ja laite analyyttitason määrittämiseksi kokoverinäytteestä.
DK271689A (da) Fremgangsmaade til bestemmelse af olieindhold i en undergrundsformation
DE69921272D1 (de) Mit dünnen Seilen befestigter Block
DE59712537D1 (de) Messanordnung zur bestimmung von gasbestandteilen in gasgemischen
DK265888A (da) Fremgangsmaade til bestemmelse af fructosamin
DE59101445D1 (de) Messvorrichtung zur Bestimmung von Zugkräften.
ATA900186A (de) Verfahren zur bestimmung von antikörpern gegen retroviren sowie testbesteck, retroviren cbl-1 und retroviren cbl-1-antigene hiefür
DE69719392D1 (de) System zur Bestimmung von Gaskonzentration
EP0836652A4 (de) Methoden, probensätze und zusammensetzungen für den nachweis von papillomavirus
KR930700548A (ko) 자궁내막 항체 측정방법 및 측정용 자궁내막 항원, 조성물, 테스트킷
DK331389A (da) Fremgangsmaade til bestemmelse af pyrogenindhold

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties